Literature DB >> 16436571

Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.

Kevin P Weinfurt1, Michaela A Dinan, Jennifer S Allsbrook, Joëlle Y Friedman, Mark A Hall, Kevin A Schulman, Jeremy Sugarman.   

Abstract

PURPOSE: To document the current state of institutional review board (IRB) and conflict of interest committee policies regarding disclosures of financial conflicts of interest to potential research participants, and to use this information to identify and share models for effectively achieving disclosure.
METHOD: The authors identified the 123 U.S. academic medical centers that have IRBs and sought their IRB and institutional policies regarding financial conflicts of interest. In February and March 2004, using manual and key word searches, each institution's Web site was searched to identify documents containing information regarding the disclosure of financial conflicts of interest. Letters were sent to 24 institutions that had either no information or incomplete information posted on their Web sites. To assess institutions' guidelines for disclosure, the authors extracted and content coded each institution's information on disclosure.
RESULTS: Relevant information was obtained from 120 (98%) academic medical centers (AMCs), of which 57 (48%) mentioned disclosing financial conflicts to potential research participants. Of these 57, 33 (58%) included verbatim language that could be used in informed consent documents. AMCs' recommendations and requirements for disclosure included details of the financial arrangement, administrative management of conflicts of interest, and encouragement of dialogue between the investigator and the potential research participant.
CONCLUSIONS: Considerable variability exists concerning the specific information that should be disclosed. Most of the AMCs' policies were consistent with the goal of protection from legal liability. Significant questions remain, however, concerning the goals of disclosure and the most effective methods for achieving those goals.

Entities:  

Mesh:

Year:  2006        PMID: 16436571      PMCID: PMC1820630          DOI: 10.1097/00001888-200602000-00003

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  12 in total

1.  Regulating through information: disclosure laws and American health care.

Authors:  W M Sage
Journal:  Columbia Law Rev       Date:  1999-11

2.  A national survey of policies on disclosure of conflicts of interest in biomedical research.

Authors:  S V McCrary; C B Anderson; J Jakovljevic; T Khan; L B McCullough; N P Wray; B A Brody
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

4.  Expanding disclosure of conflicts of interest: the views of stakeholders.

Authors:  Baruch A Brody; Cheryl Anderson; S Van McCrary; Laurence McCullough; Robert Morgan; Nelda Wray
Journal:  IRB       Date:  2003 Jan-Feb

5.  Financial conflict-of-interest policies in clinical research: issues for clinical investigators.

Authors:  Elizabeth A Boyd; Mildred K Cho; Lisa A Bero
Journal:  Acad Med       Date:  2003-08       Impact factor: 6.893

6.  (Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986].

Authors:  A M Capron
Journal:  Med Humanit Rev       Date:  1987-01

7.  Disclosing conflicts of interest to research subjects: an ethical and legal analysis.

Authors:  David B Resnik
Journal:  Account Res       Date:  2004 Apr-Jun       Impact factor: 2.622

8.  Conflicts of interest in academic research: policies, processes, and attitudes.

Authors:  Shira Lipton; Elizabeth A Boyd; Lisa A Bero
Journal:  Account Res       Date:  2004 Apr-Jun       Impact factor: 2.622

9.  Managing conflicts of interest in the conduct of clinical trials.

Authors:  Karine Morin; Herbert Rakatansky; Frank A Riddick; Leonard J Morse; John M O'Bannon; Michael S Goldrich; Priscilla Ray; Matthew Weiss; Robert M Sade; Monique A Spillman
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

10.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

View more
  14 in total

1.  Re-envisioning our approach to research in academia.

Authors:  Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  Ethical issues in surgical research.

Authors:  Patrick J McDonald; Abhaya V Kulkarni; Forough Farrokhyar; Mohit Bhandari
Journal:  Can J Surg       Date:  2010-04       Impact factor: 2.089

3.  The limits of disclosure: what research subjects want to know about investigator financial interests.

Authors:  Christine Grady; Elizabeth Horstmann; Jeffrey S Sussman; Sara Chandros Hull
Journal:  J Law Med Ethics       Date:  2006       Impact factor: 1.718

4.  Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.

Authors:  Kevin P Weinfurt; Joëlle Y Friedman; Michaela A Dinan; Jennifer S Allsbrook; Mark A Hall; Jatinder K Dhillon; Jeremy Sugarman
Journal:  J Law Med Ethics       Date:  2006       Impact factor: 1.718

5.  Developing model language for disclosing financial interests to potential clinical research participants.

Authors:  Kevin P Weinfurt; Jennifer S Allsbrook; Joëlle Y Friedman; Michaela A Dinan; Mark A Hall; Kevin A Schulman; Jeremy Sugarman
Journal:  IRB       Date:  2007 Jan-Feb

6.  Comparison of conflict of interest policies and reported practices in academic medical centers in the United States.

Authors:  Michaela A Dinan; Kevin P Weinfurt; Joëlle Y Friedman; Jennifer S Allsbrook; Julie Gottlieb; Kevin A Schulman; Mark A Hall; Jatinder K Dhillon; Jeremy Sugarman
Journal:  Account Res       Date:  2006 Oct-Dec       Impact factor: 2.622

7.  Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings.

Authors:  Kevin P Weinfurt; Mark A Hall; N Chantelle Hardy; Joëlle Y Friedman; Kevin A Schulman; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2010-02-26       Impact factor: 5.128

8.  Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research.

Authors:  Alice K Fortune-Greeley; N Chantelle Hardy; Li Lin; Joëlle Y Friedman; Janice S Lawlor; Lawrence H Muhlbaier; Mark A Hall; Kevin A Schulman; Jeremy Sugarman; Kevin P Weinfurt
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-01-12

9.  Effects of disclosing financial interests on attitudes toward clinical research.

Authors:  Kevin P Weinfurt; Mark A Hall; Michaela A Dinan; Venita DePuy; Joëlle Y Friedman; Jennifer S Allsbrook; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

10.  Disclosure of financial relationships to participants in clinical research.

Authors:  Kevin P Weinfurt; Mark A Hall; Nancy M P King; Joëlle Y Friedman; Kevin A Schulman; Jeremy Sugarman
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.